Sign in or create an account to add this stock to your watchlist.
About Bayer (OTCMKTS:BAYRY)
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, and cosmetics in the dermatology, nutritional supplement, analgesic, digestive health, allergy, cold, foot care, and sun protection categories. The Crop Science segment offers crop protection products, seeds, non-agriculture pest control products. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to vets, farmers, and pet-owners. The company was founded in 1863 and is headquartered in Leverkusen, Germany.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:BAYRY
CUSIPN/A
Phone49-21-4-30-1
Debt
Debt-to-Equity Ratio0.34
Current Ratio2.21
Quick Ratio1.73
Price-To-Earnings
Trailing P/E Ratio15.53
Forward P/E Ratio13.23
P/E Growth2.74
Sales & Book Value
Annual Sales$39.55 billion
Price / Sales2.47
Cash Flow$2.5968 per share
Price / Cash11.36
Book Value$12.60 per share
Price / Book2.34
Profitability
EPS (Most Recent Fiscal Year)$1.90
Net Income$8.29 billion
Net Margins11.96%
Return on Equity19.26%
Return on Assets7.96%
Miscellaneous
Employees115,200
Outstanding Shares3,307,800,000
Bayer (OTCMKTS:BAYRY) Frequently Asked Questions
What is Bayer's stock symbol?
Bayer trades on the OTCMKTS under the ticker symbol "BAYRY."
How often does Bayer pay dividends? What is the dividend yield for Bayer?
Bayer declared an annual dividend on Monday, March 19th. Stockholders of record on Tuesday, May 29th will be paid a dividend of $0.614 per share on Monday, June 11th. The ex-dividend date is Friday, May 25th. View Bayer's Dividend History.
How were Bayer's earnings last quarter?
Bayer (OTCMKTS:BAYRY) released its earnings results on Wednesday, February, 28th. The company reported $0.42 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.31 by $0.11. The company had revenue of $10.12 billion for the quarter. Bayer had a net margin of 11.96% and a return on equity of 19.26%. View Bayer's Earnings History.
When is Bayer's next earnings date?
Who are some of Bayer's key competitors?
Some companies that are related to Bayer include Johnson & Johnson (JNJ), Pfizer (PFE), Novartis (NVS), AbbVie (ABBV), Merck & Co. (MRK), Novo Nordisk A/S (NVO), Abbott Laboratories (ABT), GlaxoSmithKline (GSK), Sanofi (SNY), AstraZeneca (AZN), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), Celgene (CELG), Allergan (AGN) and Shire (SHPG).
Who are Bayer's key executives?
Bayer's management team includes the folowing people:
- Mr. Werner Baumann, Chairman of Management & CEO (Age 56)
- Mr. Johannes M. Dietsch, Head of Fin. Dept, CFO - Asia/Pacific Region & Member of Management Board (Age 56)
- Mr. Liam Condon, CEO of Bayer Cropscience & Member of Management Board (Age 50)
- Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 56)
- Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 62)
Has Bayer been receiving favorable news coverage?
News articles about BAYRY stock have been trending somewhat positive on Friday, according to Accern Sentiment. Accern rates the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Bayer earned a media sentiment score of 0.12 on Accern's scale. They also gave press coverage about the company an impact score of 46.66 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.
How do I buy shares of Bayer?
Shares of BAYRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Bayer's stock price today?
One share of BAYRY stock can currently be purchased for approximately $29.50.
How big of a company is Bayer?
Bayer has a market capitalization of $99.93 billion and generates $39.55 billion in revenue each year. The company earns $8.29 billion in net income (profit) each year or $1.90 on an earnings per share basis. Bayer employs 115,200 workers across the globe.
How can I contact Bayer?
Bayer's mailing address is Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368. The company can be reached via phone at 49-21-4-30-1 or via email at [email protected]
MarketBeat Community Rating for Bayer (BAYRY)
MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
Bayer (OTCMKTS:BAYRY) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
3 Wall Street analysts have issued ratings and price targets for Bayer in the last 12 months. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.67 | 2.50 | 2.67 | 2.83 |
| Ratings Breakdown: | 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | N/A | N/A | N/A | N/A |
| Price Target Upside: | N/A | N/A | N/A | N/A |
Bayer (OTCMKTS:BAYRY) Consensus Price Target History
Bayer (OTCMKTS:BAYRY) Analyst Ratings History
Show:
(Data available from 5/25/2016 forward)
Bayer (OTCMKTS:BAYRY) Dividend Information
Bayer pays an annual dividend of $0.54 per share, with a dividend yield of 1.83%. BAYRY's next annual dividend payment will be made on Monday, June 11. Bayer pays out 28.42% of its earnings out as a dividend.
| Next Dividend: | 6/11/2018 |
| Annual Dividend: | $0.54 |
| Dividend Yield: | 1.83% |
| Payout Ratio(s): | 28.42% (Trailing 12 Months of Earnings)
24.22% (Based on This Year's Estimates)
22.31% (Based on Next Year's Estimates)
20.79% (Based on Cash Flow)
|
Bayer (OTCMKTS:BAYRY) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 3/19/2018 | Annual | $0.6140 | | 5/25/2018 | 5/29/2018 | 6/11/2018 |
| 6/29/2017 | Annual | $2.1570 | | 5/1/2017 | 5/3/2017 | 5/15/2017 |
(Data available from 1/1/2013 forward)
Bayer (OTCMKTS BAYRY) Insider Trading and Institutional Ownership History
Institutional Ownership Percentage: 0.82%
Bayer (OTCMKTS BAYRY) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Bayer (OTCMKTS BAYRY) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Journal Profile: Owner of Milk + Honey spas ready to grow nationwide
www.bizjournals.com - May 25 at 9:03 AM |
 | Bayer cuts Monsanto earnings synergies outlook by $300M
seekingalpha.com - May 25 at 9:03 AM |
 | Market Morning Roundup – Futures Down, Facebook Wants Your SSN, Fed Minutes, Weed-Killing Robots
finance.yahoo.com - May 23 at 4:52 PM |
 | Bayer Presents Preliminary Insights from Global Patient Survey at World Federation of Hemophilia 2018 World Congress
www.prnewswire.com - May 23 at 8:56 AM |
| Covestro to Cut Its Teeth on Small M&A Before Unlocking Billions
finance.yahoo.com - May 23 at 8:56 AM |
 | Comparing Bayer (BAYRY) & Its Peers
www.americanbankingnews.com - May 22 at 7:24 PM |
 | Vanessa Bayer Feared Doing The 'Porn Stars' Skit With Donald Trump On 'SNL'
www.huffingtonpost.com - May 22 at 9:01 AM |
| CCI clears Bayer's deal for Monsanto
finance.yahoo.com - May 22 at 9:01 AM |
| Indian regulator clears Bayer's deal for Monsanto
finance.yahoo.com - May 22 at 9:01 AM |
| Bayer Declares Annual Dividend of $0.61 (BAYRY)
www.americanbankingnews.com - May 20 at 8:00 AM |
| El futbolista Jérôme Boateng prepara una colección de diseño con /Nyden
www.prnewswire.com - May 17 at 10:30 PM |
| Le footballeur Jérôme Boateng va dessiner une collection avec /Nyden
www.prnewswire.com - May 17 at 8:15 PM |
| Piłkarz Jérôme Boateng zaprojektuje kolekcję z /Nyden
www.prnewswire.com - May 17 at 6:27 PM |
| Bayer (BAYRY) Rating Reiterated by DZ Bank
www.americanbankingnews.com - May 17 at 4:52 PM |
 | BRIEF-Bayer Cropscience Agreed To Settle A Lawsuit Brought By Calyxt In Delaware Chancery Court
www.reuters.com - May 16 at 9:22 AM |
| Bayer to Present Pulmonary Hypertension Data at the American Thoracic Society 2018 International Conference
www.prnewswire.com - May 15 at 9:37 AM |
| Why Bayer Aktiengesellschaft (BAYRY) Might Surprise This Earnings Season
finance.yahoo.com - May 15 at 9:37 AM |
| Jan Price, National Director of Women's HealthCare and Neurology Medical Science Liaisons Teams at Bayer ...
www.prnewswire.com - May 11 at 9:54 AM |
| BRIEF-Bayer Receives Approval For Eylea In China
www.reuters.com - May 11 at 9:54 AM |
| Roche's doublet therapy fails to beat Bayer's Stivarga in late-stage CRC study
seekingalpha.com - May 10 at 7:31 AM |
 | Monsanto CEO to Leave After Sale to Bayer
www.wsj.com - May 9 at 9:13 AM |
 | Face of GMOs at Monsanto to Step Down as Bayer Takeover Closes
www.bloomberg.com - May 8 at 9:07 AM |
| BRIEF-Monsanto CEO Announces Intent To Leave Co Upon Closing Of Bayer Acquisition
www.reuters.com - May 7 at 9:02 AM |
 | Monsanto CEO Hugh Grant to step down after Bayer deal closes
www.theglobeandmail.com - May 7 at 9:02 AM |
| Monsanto CEO Hugh Grant says he will step down once the Bayer deal closes
finance.yahoo.com - May 7 at 9:02 AM |
| Monsanto says CEO Hugh Grant will step down after Bayer deal closes
finance.yahoo.com - May 7 at 9:02 AM |
| Bayer (BAYRY) Cut to "Sell" at ValuEngine
www.americanbankingnews.com - May 5 at 2:27 PM |
| Bayer's (BAYZF) CEO Werner Baumann on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 4 at 9:05 AM |
 | BASF: No key savings from Bayer agriculture assets
www.marketwatch.com - May 4 at 9:05 AM |
| Bayer sells further Covestro stake for 2.2 billion euros
finance.yahoo.com - May 4 at 9:05 AM |
| Bayer A.G. beats by €0.20, misses on revenue
seekingalpha.com - May 3 at 6:31 AM |
| Bayer (BAYRY) Upgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - May 2 at 12:25 PM |
| BRIEF-Cadila Healthcare Gets Exit Price For Sale Of Shares To Bayer (South East Asia)
www.reuters.com - May 2 at 9:08 AM |
| What's in the Offing for Regeneron (REGN) in Q1 Earnings?
finance.yahoo.com - May 1 at 9:11 AM |
| EU approves BASF deal to buy Bayer assets
www.marketwatch.com - April 30 at 9:18 AM |
| BRIEF-Cadila Healthcare To Sell 12.5 Mln Shares Of JV To Bayer (South East Asia)
www.reuters.com - April 27 at 9:38 AM |
| Bayer, Monsanto deal could be approved in US by end of May: Report
www.bizjournals.com - April 26 at 8:59 AM |
| Bayer, Monsanto deal on track for U.S. approval by end of May - source
finance.yahoo.com - April 26 at 8:59 AM |
| Bayer (BAYRY) Lowered to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 18 at 7:30 PM |
| BRIEF-Evotec Says Endometriosis Programme With Bayer Moves To Phase I Development
www.reuters.com - April 18 at 9:12 AM |
| Preclinical Data Presented by Bayer at AACR Highlights BAY 1905254, Formerly the CGEN-15001T Program, Efficacy ...
www.prnewswire.com - April 17 at 9:31 AM |
| Bayer to sell $3.7 bln of new shares to Temasek
www.marketwatch.com - April 17 at 9:31 AM |
| The US Approves Bayer And Monsanto's Merger
seekingalpha.com - April 17 at 9:31 AM |
| Professional Life Coach Mike Bayer Joins Daytime Television's #1 Rated Talk Show Dr. Phil as 'Coach Mike'
www.prnewswire.com - April 16 at 4:39 PM |
 | Easton Pharmaceuticals Announces BAYER Agreement Update
globenewswire.com - April 16 at 9:03 AM |
| BRIEF-Easton Pharmaceuticals Says Agreement with Bayer and Its Unit Has Closed
www.reuters.com - April 16 at 9:03 AM |
| BASF to Crank Up R&D `Two Gears' With Bayer Seeds, Next CEO Says
www.bloomberg.com - April 16 at 9:03 AM |
| Brokers Set Expectations for Bayer's Q1 2018 Earnings (BAYRY)
www.americanbankingnews.com - April 16 at 1:44 AM |
| Bayer to sell digital farming business to win approval for Monsanto deal
finance.yahoo.com - April 11 at 9:45 AM |
 | European shares led higher by Bayer, luxury stocks
www.nasdaq.com - April 10 at 9:33 AM |
Bayer (OTCMKTS:BAYRY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Bayer (OTCMKTS:BAYRY) Income Statement, Balance Sheet and Cash Flow Statement
Bayer (OTCMKTS BAYRY) Stock Chart for Friday, May, 25, 2018
Loading chart…
